MiT family translocation carcinomas (tRCC) are characterized by translocations involving breakpoint lesions at Xp11.2 and are frequently fused with the TFE3 gene [17, 18]. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.